CSF3 and type 1 diabetes mellitus: In streptozotocin (STZ)-induced type 1 diabetes (T1D) rat models and high glucose-treated H9c2 cells, G-CSF treatment significantly reduces expression of Bip, caspase-9/12, IRE1α, and CHOP in myocardial tissue and cells (115).